[31 January 2019] The IBTA’s monthly e-News has been released and has emailed to all subscribers. To sign up to receive your copy, click here.
You can also read the IBTA e-News January 2019 edition in full online here.
Some of the highlights from this month’s round-up:
- New research has identified sex differences in glioblastoma, suggesting that tailoring treatments to men and women, based on the molecular subtypes of their tumours, may improve survival for all patients.
- An article in the magazine Cancer World highlights recent advances in the molecular profiling of brain metastases by analysing circulating tumour cells (CTCs).
- In a report published in Nature, researchers say they have shown that a personalized ‘neoantigen’ vaccine can spur a response against glioblastoma.
- Australian researchers are developing a blood test which they hope will monitor brain tumours more accurately and allow doctors to assess whether they are stable or growing
- Research published in the journal Clinical Cancer Research has found B7-H3 is a promising target for CAR-T cell therapy in paediatric brain tumours.
- A research team at the University of Oxford, UK, has launched a survey on clinical trial participation as part of an initiative called The Rare Cancer Project, which is seeking responses from people living in the UK living with a brain tumour. The survey aims to capture information about clinical trial enrolment from the perspective of patients, legal guardians and caregivers.
- A Californian brain tumour patient who did not qualify as a clinical trial participant is set to become the first person to access an experimental treatment under the United States’ controversial Right to Try Act.
- A systematic literature review shows that there is a small but growing body of neuro-oncology related research from Nigeria.
Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.
To see an archive of existing e-News issues, click here.
